- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Firms open Shanghai facilities
Bracco is consolidating operations in China. A production plant of Bracco-SINE Pharmaceutical, the joint venture formed by the Italian group with one of China's primary pharmaceuticals companies, is opening in Pudong (Shanghai). The new plant, which
Bracco is consolidating operations in China. A production plant of Bracco-SINE Pharmaceutical, the joint venture formed by the Italian group with one of China's primary pharmaceuticals companies, is opening in Pudong (Shanghai). The new plant, which covers 2000 square meters, will produce contrast media for diagnostic imaging systems. It focuses on the final cycle in contrast media production. Basic substances sent from Italy are processed into solutions, then prepared, sealed, and sterilized into injectible products. The market for contrast media is expected to rise in China by an annual 20% to 30%.
Canadian software developer Cedara has opened a new office in Shanghai. The company's PACS products are already being sold by some of the country's leading medical equipment manufacturers. Cedara's new Chinese office is another step toward establishing a larger presence in the region, according to the company. The Shanghai office will provide local sales, support, and training to the company's Chinese customer base, as well as to customers in the Asia-Pacific region.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,00 women with no prior history of breast cancer.
CT Study Links Pleural Effusion and Higher 30-Day Mortality Rates in Patients with COVID-19
October 1st 2024In a multicenter study of over 1,100 patients with COVID-19, pleural effusion was detected on CT scans in nearly a third of patients, who also had significantly higher ICU admission and 30-day mortality rates.
